Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Superior vena cava syndrome.

J A Bilyeu1

  • 1Country Life Insurance Company, PO Box 2000, Bloomington, IL 61702-2000, USA.

Journal of Insurance Medicine (New York, N.Y.)
|March 7, 2002
PubMed
Summary

Superior vena cava (SVC) obstruction affects 15,000 people yearly, often due to cancer. This case highlights sclerosing mediastinitis, a benign condition causing recurrent SVC obstruction and significant patient morbidity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic eosinophilic pneumonia.

Journal of insurance medicine (New York, N.Y.)ยท1999
See all related articles

Area of Science:

  • Vascular Medicine
  • Thoracic Surgery
  • Oncology

Background:

  • Superior vena cava (SVC) obstruction impacts approximately 15,000 individuals annually in the U.S.
  • Malignancies account for 80-85% of SVC obstruction cases, with lung cancer being the most prevalent.
  • Benign conditions cause 15-20% of SVC obstructions, including sclerosing mediastinitis.

Observation:

  • Sclerosing mediastinitis, a benign fibrotic condition, was the cause of SVC obstruction in this case.
  • Despite advances in vascular techniques and thrombolytic therapy, outcomes for SVC obstruction remain a concern.
  • Sclerosing mediastinitis is a progressive fibrotic process that is challenging to treat surgically.

Findings:

  • Sclerosing mediastinitis can lead to recurrent episodes of SVC obstruction.
  • Surgical removal of sclerosing mediastinitis is often not feasible due to its nature.
  • Repetitive vascular procedures are frequently required for managing recurrent SVC obstruction.

Implications:

  • Recurrent SVC obstruction from sclerosing mediastinitis can lead to significant patient morbidity.
  • The fibrotic nature of sclerosing mediastinitis poses long-term management challenges.
  • Further research into less invasive and more effective treatments for benign SVC obstruction is warranted.

Related Experiment Videos